ArticleProceedings of the National Academy of Sciences of the United States of America2024

TRAF3 loss-of-function reveals the noncanonical NF-κB pathway as a therapeutic target in diffuse large B cell lymphoma.

Michael Y Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.